Skip to main content

Table 4 Clinical presentations and outcome by diagnostic category

From: Repeated Aspergillusisolation in respiratory samples from non-immunocompromised patients not selected based on clinical diagnoses: colonisation or infection?

 

Total

Colonised

Aspergillosis

   

Probable

Proven

Probable + Proven

No. patients

245

106

125

14

139

Invasive pulmonary aspergillosis

77 (31.4)

 

68 (54.4)

10 (71.4)

78 (56.1)

Chronic pulmonary aspergillosis

23 (9.4)

 

19 (15.2)

4 (28.6)

23 (16.5)

Simple tracheobronchitis

26 (10.6)

 

26 (20.8)

0 (0.0)

26 (18.7)

Invasive tracheobronchitis

12 (4.9)

 

12 (9.4)

0 (0.0)

12 (8.6)

Mortality

76 (31.0)

13 (12.3)

52 (41.6)a

11 (78.6)a,b

63 (45.3)a

a) Death attributable to Aspergillus

7 (2.9)

0 (0.0)

4 (3.2)

3 (21.4)a, b

7 (5.0)

b) Death attributable to Aspergillus and to other causes

44 (18.0)

0 (0.0)

36 (28.8)a

8 (57.1)a

44 (31.7)a

a) + b)

51 (20.9)

0 (0.0)

40 (32.0)a

11 (78.5)a, b

51 (36.7)

Death not attributable to Aspergillus

25 (10.2)

13 (12.3)

12 (9.6)

0 (0.0)

12 (8.6)

  1. Results are expressed as “n (%)”
  2. ap < 0.001 vs. colonised; bp < 0.02 vs. probable.